| Date | Title | Description |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies |
Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 17.09.2024 | From Glial Cells to Beta Cells: Swiss companies receive grants to tackle health challenges |
GliaPharm, an EPFL spinoff biotech company that develops innovative approaches to treat neurological and psychiatric disorders has received BRAINS grant to support a four-year study into the behavior of glial cells in various brain disease... |
| 13.09.2024 | Maximize your EIC Funding: Webinar on unlocking business opportunities with Europe’s largest corporations | The European Innovation Council (EIC) Corporate Partnership Programme has been instrumental in fostering collaborations between EIC-funded startups and Europe’s leading corporations. Since its launch in 2017, the programme has facilitated o... |
| 19.08.2024 | InSphero, Breakthrough T1D and Université libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes | InSphero, Breakthrough T1D, and Université Libre de Bruxelles Collaborate to Find New Cures for Type 1 Diabetes
InSphero, Breakthrough T1D, and ULB partner to discover novel T1D treatments, aiming to protect and preserve vital insulin-produ... |
| 31.05.2024 | Swiss life science startups headed for San Diego |
The BIO International Convention 2024, taking place in San Diego from 3 to 6 June, is the largest global biotechnology event with over 20,000 industry leaders from around the world attending. The target group includes representatives from ... |
| 22.05.2024 | "EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024 | ZURICH, May 22, 2024 /PRNewswire/ -- Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present 41 leading Swiss biotech stars at the SWISS BIOTECH pavilion dem... |
| 16.05.2024 | InSphero Secures Exclusive Commercialization Partnership with Genome Biologics for 3D Cardiac Organoid Platform | InSphero AG is pleased to announce its exclusive commercialization of TrueCardium® Cardiac Organoid Platform in partnership with Genome Biologics. SCHLIEREN, ZURICH, SWITZERLAND, May 16, 2024 /EINPresswire.com/ -- In a significant expansion... |
| 15.03.2024 | InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery in a Breakthrough Study | InSphero published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery. SCHLIEREN, ZURICH, SWITZERLAND, March 15, 2024 /EINPresswire.com/ -- InSphero's L... |
| 17.11.2023 | InSphero to Revolutionize Oncology Research Through Advanced 3D Cell-Based Assays with ATCC | InSphero AG and ATCC will work together to introduce new paradigms in the rapidly evolving field of 3D cell-based oncology research.
Through this partnership with ATCC, we are fulfilling a long-standing ambition to open new avenues for adva... |
| 31.03.2023 | InSphero Accelerates Launch of Cryopreserved 3D Microtissue Platform with new Investment Round Led by ZEISS Ventures | 3D InSight™ Tumor Microtissue
Allows streamlining the R&D process for researchers desiring deeper insights in human biology by storable, ready-to-use 3D models
InSphero has uniquely positioned itself with its highly industrialized platf... |
| 23.01.2023 | InSphero and Brenus Pharma are awarded EUR 1.5 million grant for cancer research project | InSphero and Brenus Pharma are awarded EUR 1.5 million grant for cancer research project 23.01.2023 12:39, Morgane Ghilardi linkedIn facebook twitter instagram youtube -->
The Eurostar funding will support a research project aiming to us... |
| 23.01.2023 | InSphero and Brenus Pharma are awarded EUR 1.5 million grant for cancer research project | The collaborative project titled "STC-1010: A First-in-Class Allogeneic Cell Vaccine Against Cancer" is coordinated by Brenus in collaboration with InSphero and was launched in November 2022 and is set to take 36 months. The colla... |
| 15.02.2022 | Welcome back to the FDA, Robert Califf. Let’s get to work on your big idea | Now, more than ever, the U.S. needs scientific leaders who value Americans’ health and safety, who want to improve research and testing, and who are passionate about innovative ideas.
With Robert Califf once again confirmed as the commissio... |
| 26.11.2020 | New prizes and grants from three continents | Heat Force – COMEUP, Korea
Selected from 1075 applicants, Heart Force from Zurich is among the 120 winners of the COMEUP Stars organised in Korea. The prize includes support for the creation of corporate promotional videos and online booths... |
| 26.11.2020 | New prizes and grants from three continents | |
| 05.08.2020 | Insphero among Red Dot’s Best of the Best Award winners | |
| 05.08.2020 | Insphero among Red Dot’s Best of the Best Award winners | The Red Dot Award recognises outstanding design achievements of designers and companies worldwide in roughly 50 categories based on criteria for excellent design standards and innovation. With more than 18,000 entries, the RedDot Award is o... |
| 19.05.2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | BIO International Convention has transformed into BIO Digital to bring together players in the biotech industry to exchange ideas even in times when it is impossible to gather physically. From 8 - 12 June, more than 2300 companies from all ... |
| 19.05.2020 | Eleven Swiss start-ups on the virtual BIO Digital stage | |
| 13.05.2020 | Swiss Startups Tackling Corona Virus - COVID-19 | Swiss Startups Tackling Corona Virus - COVID-19 13.05.2020 13:14, Gianmaria Sbetta linkedIn facebook twitter instagram youtube -->
Corona Virus is changing our society, our economy and our lifestyle. Remote working and online collaborati... |
| 26.03.2020 | Tried and tested technologies to fight Coronavirus | |
| 26.03.2020 | Tried and tested technologies to fight Coronavirus | The world is battling against the Coronavirus as different players from medical workers to government members struggle to understand the virus and develop an immunization program for it, or to find the appropriate medication to treat patien... |
| 08.11.2019 | IPO Day: Deep-tech companies on stage | |
| 07.11.2019 | In honour of Swiss innovation | |
| 17.09.2019 | Twelve Swiss startups join Euronext’s Pre-Ipo programme Techshare | |
| 24.07.2019 | Insphero’s 3D liver disease testing platform launched in the market | |
| 19.03.2019 | Thirteen Swiss startups receive Eurostars grants | |
| 30.07.2018 | Insphero collaborates with the American Laboratory Products Company | |
| 18.06.2018 | InSphero grows further with $10 million funding round | The medtech’s drug discovery and testing platforms use ground-breaking, scaffold-free 3D microtissues – phenotypic models of the smallest functional unit of a tissue or organ – driven by cellular self-assembly. With organs grown in vitro in... |
| 18.06.2018 | InSphero grows further with $10 million funding round | InSphero grows further with $10 million funding round 18.06.2018 11:10, Robynn Weldon linkedIn facebook twitter instagram youtube -->
3D cell culture pioneer Insphero has raised new financing from internal and external investors, bringin... |
| 15.06.2018 | InSphero raises additional $10m | |
| 13.06.2018 | InSphero Raises $10M in Funding | InSphero, a Schlieren, Switzerland-based provider of 3D cell-based platforms for drug discovery and efficacy testing, raised $10m in funding.
The round brings total funding to date to USD$35m. Backers included former GM of Promega Switzerla... |
| 27.04.2017 | InSphero’s micro livers to help Pfizer to predict drug-induced liver injury | |
| 29.03.2017 | InSphero reduces Animal Testing with 3D InSight™ Monkey Liver Microtissues | InSphero reduces Animal Testing with 3D InSight™ Monkey Liver Microtissues 29.03.2017 10:00, Tsering Ngorkhangsar linkedIn facebook twitter instagram youtube -->
InSphero was named #1 startup in the 2014 TOP 100 Swiss startups ranking an... |
| 29.03.2017 | InSphero reduces Animal Testing with 3D InSight™ Monkey Liver Microtissues | Drug-induced liver injury (DILI) remains one of the most common causes of late-stage failure in drug development and post-market drug withdrawal. Testing in non-human primates is often required to assess toxicity and potential liver-related... |
| 07.11.2016 | InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System | The Global 3Rs Awards recognize significant innovative contributions toward the advancement of ethical science through the 3Rs of animal research: refinement, replacement, or reduction of animal use. Early October 2016, InSphero had met wit... |
| 07.11.2016 | InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System | InSphero Scientist Receives 3Rs Award for Microtissue-based Body on a Chip System 07.11.2016 14:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
Dr. Olivier Frey of InSphero AG has received the 2016 IQ Consortium and AAALAC... |
| 03.10.2016 | InSphero discusses technologies to reduce animal research with US Congressional Leaders | InSphero discusses technologies to reduce animal research with US Congressional Leaders 03.10.2016 14:00, Lara Rossi linkedIn facebook twitter instagram youtube -->
InSphero AG, the leading supplier of easy-to-use solutions for productio... |
| 02.09.2016 | Biointerfaces: Vom Labor auf den Markt | |
| 06.06.2016 | Jan Lichtenberg im Rennen um den EY World Entrepreneur Of The Year | |
| 07.03.2016 | The search for Insphero’s successor has began | |
| 11.02.2016 | Bilan reveals its Top 50 startup selection | |
| 10.02.2016 | Almost a billion invested in Venture Kick startups | |
| 25.01.2016 | Jan Lichtenberg of InSphero: “The days in Boston were phenomenal” | The startup InSphero is committed to the production and sales of high quality micro fabrics that are very similar to real human body tissue. The so-called “microtissues” can be used for more efficient drug development, which in turn could r... |
| 23.10.2015 | Jan Lichtenberg wird Entrepreneur of the Year | |
| 12.10.2015 | Redalpine Capital I Exits InSphero | Zurich, Switzerland-based Redalpine Capital I exited InSphero, a developer of organotypic 3D cell cultures for in-vitro testing, at a double-digit multiple.
The Schlieren-based company recently closed a CHF 20m Series C funding round with t... |
| 12.10.2015 | Successful exit for Redalpine with InSphero | |
| 22.09.2015 | Vier Startups im Final des Entrepreneur of the Year Awards | |
| 16.09.2015 | Schnelle Schweizer Life Sciences Startups | |
| 05.08.2015 | InSphero Expands Global Availability of its 3D Cell Culture Platforms | |
| 08.07.2015 | TOP 100 Startup Award winner InSphero secures CHF 20 million series C financing | TOP 100 Startup Award winner InSphero secures CHF 20 million series C financing 08.07.2015 12:00, Tina Lohfing linkedIn facebook twitter instagram youtube -->
InSphero, Nr. 1 Swiss Startup of the Top 100 Swiss Startup Rankings 2014 and t... |
| 08.07.2015 | InSphero Secures CHF 20 Million Series C Financing | |
| 08.07.2015 | TOP 100 Startup Award winner InSphero secures CHF 20 million series C financing | Since its commercial launch in 2010, the company has experienced strong year-over-year sales growth marked by the rapid adoption of its 3D InSight™ microtissues and services by leading pharmaceutical, chemical and cosmetics companies. Since... |
| 08.07.2015 | Daily funding roundup - July 8, 2015 | WeWork raised $434M; Babbel nabbed $20M; Confluent closed $24M
WeWork, a company that sublets office space, along with amenities, including furniture and Internet, and other additional goodies, to budding entrepreneurs has been raising a lo... |
| 08.07.2015 | InSphero Secures CHF20M Series C Financing | InSphero, a Schlieren, Switzerland-based 3D cell culture company, raised CHF 20m in Series C financing.
The family investment office of a globally active entrepreneur represented through Zug, Switzerland-based HP Wild Holding AG made the in... |
| 29.04.2015 | Vainqueur Prix Strategis 2015: eSmart | |
| 27.03.2015 | Startups mischen Export Award auf | |
| 20.03.2015 | Finalists of Prix Strategis announced | |
| 05.02.2015 | Bilan presents 50 start-ups looking for funding | |
| 01.12.2014 | Semi-finalists of Prix Strategis announced | |
| 10.10.2014 | InSphero wins ACES Award | |
| 18.09.2014 | Swiss Top 100 Start-ups Are Selected | |
| 05.08.2014 | InSphero finalist of the 2014 European academic enterprise awards | |
| 11.07.2014 | Insphero to enter the personalized medicine market with a new spin-off | |
| 07.07.2014 | Die Startupfair 2014 setzt neue Massstäbe | |
| 05.06.2014 | Eight start-ups selected for the Swiss Venture Day in Zurich | |
| 02.06.2014 | Startup-Battle 2014: Die Hightech-Finalisten stehen fest | |
| 07.05.2014 | Europäische Forschungsprogramme: Was für Startups auf dem Spiel steht | |
| 03.03.2014 | InSphero Granted Hanging Drop Patents in China and Japan | |
| 07.02.2014 | Startups schaffen 2`433 Jobs | |
| 16.01.2014 | Application open for venture leaders | |
| 05.12.2013 | InSphero gets funds from EUROSTARS for novel liver screening platform | |
| 26.11.2013 | InSphero opens EU office for speeding up delivery | |
| 02.10.2013 | Finalisten des Entrepreneur Of The Year-Wettbewerbs 2013 stehen fest | |
| 19.09.2013 | Insights and background information from the Top 100 Startups Awards | |
| 18.09.2013 | Housetrip erneut an die Spitze der Top 100 Start-ups gewählt | |
| 12.07.2013 | Pfizer und Roche veröffentlichen positive Studienresultate mit InSphero | |
| 18.06.2013 | InSphero Receives CHF2M in Series B Financing | InSphero AG, a Zurich, Switzerland-based provider of three-dimensional microtissue technology, received CHF2m in Series B financing.
The round – a mixture of equity capital and long-term loans – was led by unnamed existing and new investors... |
| 13.06.2013 | InSphero secures CHF 2 million financing | |
| 31.01.2013 | Insphero: Patent and New Product | |
| 22.11.2012 | Taiwanischer Minister zu Besuch bei venturelab | Anlass des Besuches der taiwanesischen Delegation ist eine alle vier Jahre stattfindende Konferenz zu Wissenschaft und Technologie. Eines der wichtigen Themen ist die berufliche Ausbildung und die Kooperation zwischen Hochschule und Industr... |
| 29.10.2012 | Top 100 Startup 2012: Housetrip auf Platz 1 | |
| 14.09.2012 | Cyprotex to offer testing service using InSphero technology | |
| 24.07.2012 | InSphero coordinates European Union project | |
| 03.07.2012 | InSphero Launches Human Liver Microtissues | |
| 18.06.2012 | InSphero with new product, new employee in the US and new nomination | |
| 18.05.2012 | Pix4d and SWISSto12 get the final 100'000 kick | The first round of the private funding initiative focused on the quality of the business ideas presented by the two companies, which at that point in time, weren’t allowed to be established yet. In the following two rounds, both start-ups h... |
| 28.03.2012 | InSphero wins CTI grant to develop 3D cardiac microtissues | |
| 05.08.2010 | InSphero secures Series A financing | InSphero secures Series A financing 05.08.2010 00:00, Pascal Vermot linkedIn facebook twitter instagram youtube -->
InSphero AG, a supplier of novel 3D cell-based assays for efficacy testing and toxicology, announced it has secured 1.8 m... |
| 05.08.2010 | InSphero secures Series A financing | InSphero secures Series A financing 05.08.2010 00:00, Pascal Vermot linkedIn facebook twitter instagram youtube -->
InSphero AG, a supplier of novel 3D cell-based assays for efficacy testing and toxicology, announced it has secured 1.8 m... |
